206 Ortho was issued a U.S. patent covering a new bio-inspired composite and implants that could fix broken bones without the need for implant removal.Â
Smith & Nephew issued an Urgent Field Safety Notice affecting certain first-generation JOURNEY BCSÂ components due to a higher than expected revision rate.Â
Results from an efficacy study of ReVivo Medical's spinal fusion technology demonstrated that loadsharing through elastic micro-motion accelerates bone formation and interbody fusion.
Bioventus entered into a definitive agreement to divest its next-gen bone morphogenetic protein development program to Viscogliosi Brothers. The transaction is slated to close in 3Q18.
Revo Health and Medtronic entered into a strategic partnership to deliver patient-payment models and enhance outcomes. Medtronic has also made a minority investment in Revo.